<DOC>
	<DOCNO>NCT00003742</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase I trial study effectiveness combination chemotherapy treat patient locally advance metastatic solid tumor .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Patients With Locally Advanced Metastatic Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : I . Determine maximum tolerate dose paclitaxel combine cisplatin irinotecan patient locally advance metastatic solid tumor . II . Determine dose limit toxicity paclitaxel combine cisplatin irinotecan patient population . III . Establish recommend phase II dose regimen patient population . IV . Assess antitumor activity regimen select solid tumor malignancy . OUTLINE : This dose escalation study paclitaxel . All patient receive paclitaxel IV 1 hour , cisplatin IV 30 minute , follow irinotecan IV 30 minute weekly 4 week day 1 , 8 , 15 , 22 . Treatment repeat every six week least 3 course absence disease progression unacceptable toxicity . Cohorts 3-6 patient receive escalate dos paclitaxel . If 2 patient experience dose limit toxicity ( DLT ) particular dose level , escalation cease maximum tolerate dose ( MTD ) define previous dose level . Patients follow death . PROJECTED ACCRUAL : Approximately 12-27 patient accrue study within 6-9 month .</detailed_description>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically prove locally advanced ( unresectable recurrent ) metastatic solid tumor No bone metastasis , abnormal radionuclide bone scan pleural effusion sole indicator disease No CNS metastases carcinomatous meningitis PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 70100 % Life expectancy : Not specify Hematopoietic : WBC least 3,000/mm3 Neutrophil count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 1.5 mg/dL AST great 3 time upper limit normal ( ULN ) ( great 5 time ULN liver metastasis present ) No Gilbert 's Disease Renal : Creatinine great 1.5 mg/dL Serum calcium le 12.0 mg/dL No symptomatic hypercalcemia Cardiovascular : No unstable angina No active angina No New York Heart Association class III IV heart disease No uncontrolled asymptomatic congestive cardiac failure At least 6 month since myocardial infarction Pulmonary : No interstitial pulmonary fibrosis Other : No history seizure disorder receive phenytoin , phenobarbital , antiepileptic medication No active uncontrolled infection No uncontrolled diabetes mellitus Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : One prior chemotherapy regimen allow Endocrine therapy : Not specify Radiotherapy : At least 4 week since prior radiotherapy recover No prior mantle , hemibody , pelvic , lumbar spine irradiation Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>